Trial · NCT02411110
Adverse events76
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 76
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | LiRIS Placebo (Treatment Period 1) | 1 | 66 | |
| other | Nausea | Gastrointestinal disorders | LiRIS® (Treatment Period 1) | 4 | 65 | |
| other | Nausea | Gastrointestinal disorders | LiRIS Placebo (Treatment Period 1)/LiRIS® (Treatment Period 2) | 2 | 48 | |
| other | Nausea | Gastrointestinal disorders | LiRIS® (Treatment Period 1)/LiRIS® (Treatment Period 2) | 2 | 50 | |
| other | Urinary tract infection | Infections and infestations | LiRIS Placebo (Treatment Period 1) | 16 | 66 | |
| other | Urinary tract infection | Infections and infestations | LiRIS® (Treatment Period 1) | 10 | 65 | |
| other | Urinary tract infection | Infections and infestations | LiRIS Placebo (Treatment Period 1)/LiRIS® (Treatment Period 2) | 4 | 48 | |
| other | Urinary tract infection | Infections and infestations | LiRIS® (Treatment Period 1)/LiRIS® (Treatment Period 2) | 4 | 50 | |
| other | Vulvovaginal mycotic infection | Infections and infestations | LiRIS Placebo (Treatment Period 1) | 4 | 66 | |
| other | Vulvovaginal mycotic infection | Infections and infestations | LiRIS® (Treatment Period 1) | 3 | 65 | |
| other | Vulvovaginal mycotic infection | Infections and infestations | LiRIS Placebo (Treatment Period 1)/LiRIS® (Treatment Period 2) | 0 | 48 | |
| other | Vulvovaginal mycotic infection | Infections and infestations | LiRIS® (Treatment Period 1)/LiRIS® (Treatment Period 2) | 2 | 50 | |
| other | Procedural pain | Injury, poisoning and procedural complications | LiRIS Placebo (Treatment Period 1) | 2 | 66 | |
| other | Procedural pain | Injury, poisoning and procedural complications | LiRIS® (Treatment Period 1) | 6 | 65 | |
| other | Procedural pain | Injury, poisoning and procedural complications | LiRIS Placebo (Treatment Period 1)/LiRIS® (Treatment Period 2) | 2 | 48 | |
| other | Procedural pain | Injury, poisoning and procedural complications | LiRIS® (Treatment Period 1)/LiRIS® (Treatment Period 2) | 0 | 50 | |
| other | Dysuria | Renal and urinary disorders | LiRIS Placebo (Treatment Period 1) | 11 | 66 | |
| other | Dysuria | Renal and urinary disorders | LiRIS® (Treatment Period 1) | 13 | 65 | |
| other | Dysuria | Renal and urinary disorders | LiRIS Placebo (Treatment Period 1)/LiRIS® (Treatment Period 2) | 0 | 48 | |
| other | Dysuria | Renal and urinary disorders | LiRIS® (Treatment Period 1)/LiRIS® (Treatment Period 2) | 2 | 50 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02411110/events